lazertinib
Showing 26 - 27 of 27
Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Lazertinib, Amivantamab Subcutaneous and Co-Formulated with
Recruiting
- Advanced or Metastatic Non-small Cell Lung Cancer
- Lazertinib
- +2 more
-
Duarte, California
- +208 more
Jan 31, 2023
Carcinoma, Non-small-Cell Lung Trial in Worldwide (Amivantamab, Lazertinib, Carboplatin)
Not yet recruiting
- Carcinoma, Non-small-Cell Lung
- Amivantamab
- +3 more
-
Westwood, Kansas
- +47 more
Aug 17, 2022